INVIVYD, INC.

EDGAR

Annual consolidated revenue for 2025: about USD 53.43M, using the latest reported figures. The previous period, 2024, was about USD 25.38M.

Watchlist

Latest quarter

Revenue

14.3 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating margin

-320.76%

2026 Q2 · %

Exact inputs and evidence
  • Operating Income: -45820000 USD Source
  • Revenue: 14285000 USD Source

Operating cash flow

-43 million USD

2026 Q2 · USD

Exact inputs and evidence
  • Operating Cash Flow: -84717000 USD Source
  • Operating Cash Flow: -41712000 USD Source

Free cash flow

-43.5 million USD

2026 Q2 · USD

Exact inputs and evidence
  • Operating Cash Flow: -84717000 USD Source
  • Operating Cash Flow: -41712000 USD Source
  • Capital Expenditure: 1236000 USD Source
  • Capital Expenditure: 726000 USD Source
Cash and cash equivalents
160 million USD Source
Exact value

160080000 USD

Long-term debt including current maturities
Not available
Shares outstanding
295 million shares Source
Exact value

294755090 shares

Reported share-count change

145.34% · 175 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 120142811 shares · 2025-06-30· Source
  • 294755090 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

58.4 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Revenue: 13129000 USD · 2025-07-01 – 2025-09-30 Source
  • Revenue: 53426000 USD · 2025-01-01 – 2025-12-31 Source
  • Revenue: 36219000 USD · 2025-01-01 – 2025-09-30 Source
  • Revenue: 13744000 USD · 2026-01-01 – 2026-03-31 Source
  • Revenue: 14285000 USD · 2026-04-01 – 2026-06-30 Source

Net income

-107 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Net income: -10470000 USD · 2025-07-01 – 2025-09-30 Source
  • Net income: -52489000 USD · 2025-01-01 – 2025-12-31 Source
  • Net income: -41419000 USD · 2025-01-01 – 2025-09-30 Source
  • Net income: -41400000 USD · 2026-01-01 – 2026-03-31 Source
  • Net income: -44393000 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

-108 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Operating cash flow: -42680000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -34430000 USD · 2025-01-01 – 2025-06-30 Source
  • Operating cash flow: -58135000 USD · 2025-01-01 – 2025-12-31 Source
  • Operating cash flow: -42680000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -41712000 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: -84717000 USD · 2026-01-01 – 2026-06-30 Source
  • Operating cash flow: -41712000 USD · 2026-01-01 – 2026-03-31 Source

Capital expenditure

1.24 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Capital expenditure: 155000 USD · 2025-01-01 – 2025-09-30 Source
  • Capital expenditure: 155000 USD · 2025-01-01 – 2025-06-30 Source
  • Capital expenditure: 155000 USD · 2025-01-01 – 2025-12-31 Source
  • Capital expenditure: 155000 USD · 2025-01-01 – 2025-09-30 Source
  • Capital expenditure: 726000 USD · 2026-01-01 – 2026-03-31 Source
  • Capital expenditure: 1236000 USD · 2026-01-01 – 2026-06-30 Source
  • Capital expenditure: 726000 USD · 2026-01-01 – 2026-03-31 Source

Free cash flow

-110 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Operating cash flow: -42680000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -34430000 USD · 2025-01-01 – 2025-06-30 Source
  • Operating cash flow: -58135000 USD · 2025-01-01 – 2025-12-31 Source
  • Operating cash flow: -42680000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -41712000 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: -84717000 USD · 2026-01-01 – 2026-06-30 Source
  • Operating cash flow: -41712000 USD · 2026-01-01 – 2026-03-31 Source
  • Capital expenditure: 155000 USD · 2025-01-01 – 2025-09-30 Source
  • Capital expenditure: 155000 USD · 2025-01-01 – 2025-06-30 Source
  • Capital expenditure: 155000 USD · 2025-01-01 – 2025-12-31 Source
  • Capital expenditure: 155000 USD · 2025-01-01 – 2025-09-30 Source
  • Capital expenditure: 726000 USD · 2026-01-01 – 2026-03-31 Source
  • Capital expenditure: 1236000 USD · 2026-01-01 – 2026-06-30 Source
  • Capital expenditure: 726000 USD · 2026-01-01 – 2026-03-31 Source

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-13.

Financial data available through: 2025-12-31.

Coverage by financial measure
  • Revenue: 3 of 11 periods available· newest 2025-12-31
  • Operating income: 5 of 11 periods available· newest 2025-12-31
  • Net income: 8 of 11 periods available· newest 2025-12-31
  • Operating cash flow: 5 of 11 periods available· newest 2025-12-31
  • Capital expenditure: 5 of 11 periods available· newest 2025-12-31
  • Total assets: 3 of 11 periods available· newest 2025-12-31
  • Total liabilities: 3 of 11 periods available· newest 2025-12-31
  • Current assets: 3 of 11 periods available· newest 2025-12-31
  • Current liabilities: 3 of 11 periods available· newest 2025-12-31
  • Cash and cash equivalents: 3 of 11 periods available· newest 2025-12-31
  • long term debt: No compatible figures in this window
  • Shares outstanding: 3 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    +110.5%

    Prior period

    USD 25.38 million

    –

    Current period

    USD 53.43 million

    –

    Exact inputs and evidence

    53426000 − 25384000 = 28042000 USD

    25384000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    53426000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Net income

    +USD 117.44 million

    Prior period

    −USD 169.93 million

    –

    Current period

    −USD 52.49 million

    –

    Exact inputs and evidence

    -52489000 − -169925000 = 117436000 USD

    -169925000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -52489000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +USD 112.36 million

    Prior period

    −USD 170.49 million

    –

    Current period

    −USD 58.14 million

    –

    Exact inputs and evidence

    -58135000 − -170491000 = 112356000 USD

    -170491000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -58135000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    +10.7%

    Prior period

    USD 140,000

    –

    Current period

    USD 155,000

    –

    Exact inputs and evidence

    155000 − 140000 = 15000 USD

    140000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    155000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

  • Revenue USD 53.43 million 100% of revenue
  • Operating costs Derived USD 108.99 million 204% of revenue
  • Operating income −USD 55.56 million −104% of revenue
  • Tax, interest and other Derived −USD 3.07 million −5.7% of revenue
  • Net income −USD 52.49 million −98% of revenue

Cash

  • Operating cash flow −USD 58.14 million −109% of revenue
  • Capital expenditure USD 155,000 0.3% of revenue
  • Free cash flow Derived −USD 58.29 million −109% of revenue

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2023 Not shown: operating income or net income is not reported.
  • 2024 Operating loss: operating costs were 797% of revenue.
  • 2025 Operating loss: operating costs were 204% of revenue.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2023 2023-01-01 – 2023-12-310 212758000 Derived -212758000 -14115000 Derived -198643000 -173779000 Derived
Source
2024 2024-01-01 – 2024-12-3125384000 202260000 Derived -176876000 -6951000 Derived -169925000 -170631000 Derived
Source
2025 2025-01-01 – 2025-12-3153426000 108986000 Derived -55560000 -3071000 Derived -52489000 -58290000 Derived
Source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 53.4M 2025
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.57.7M43.3M28.9M14.4M0.0202320242025
Values and sources
Revenue values and source evidence
PeriodSeriesValue(USD)Source evidence
2023Revenue0
2024Revenue25384000
2025Revenue53426000

Revenue growth

Change in revenue from the same financial period one year earlier.

110.5% 2025
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.119%89%60%30%0%202320242025
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2023Year over yearNo prior comparable period
2024Year over yearNo prior comparable period
2025Year over year110.5%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -104% 2025
Net margin -98.2% 2025
Free cash flow margin -109.1% 2025
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.56%-146%-348%-550%-753%202320242025
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2023Operating marginNot reported
2024Operating margin-696.8%
2025Operating margin-104%
2023Net marginNot reported
2024Net margin-669.4%
2025Net margin-98.2%
2023Free cash flow marginNot reported
2024Free cash flow margin-672.2%
2025Free cash flow margin-109.1%

Operating cash flow

Cash generated by the company’s normal business operations.

USD -58.1M 2025
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.13.9M-36.4M-86.6M-136.8M-187.0M202320242025
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2023Operating cash flow-173164000
2024Operating cash flow-170491000
2025Operating cash flow-58135000

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -58.3M 2025
Free cash flow historyOperating cash flow minus capital expenditure for the same period and unit. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.13.9M-36.5M-86.9M-137.3M-187.7M202320242025
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2023Free cash flow-173779000
2024Free cash flow-170631000
2025Free cash flow-58290000

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

12.8% 2025
Liabilities to assets historyTotal liabilities as a share of total assets. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.52%39%26%13%0%202320242025
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2023Liabilities / assets22.6%
2024Liabilities / assets47.9%
2025Liabilities / assets12.8%

Current assets to current liabilities

Current assets divided by current liabilities.

7.24× 2025
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.7.82×5.87×3.91×1.96×0.00×202320242025
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2023Current assets / current liabilities4.47×
2024Current assets / current liabilities1.62×
2025Current assets / current liabilities7.24×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2021 2020-04-01 – 2021-03-31
−USD 38.7 million
Exact value

Exact value: -38700000 USD

2020-04-01 – 2021-03-31: -38700000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.

2021 2020-07-01 – 2021-06-30
−USD 83.37 million
Exact value

Exact value: -83373000 USD

2020-07-01 – 2021-06-30: -83373000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.

2021 2020-10-01 – 2021-09-30
−USD 143.75 million
Exact value

Exact value: -143748000 USD

2020-10-01 – 2021-09-30: -143748000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.

2021 2021-01-01 – 2021-12-31
−USD 226.79 million
Exact value

Exact value: -226790000 USD

2021-01-01 – 2021-12-31: -226790000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 184.74 million
Exact value

Exact value: -184736000 USD

2021-01-01 – 2021-12-31: -184736000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 84,000
Exact value

Exact value: 84000 USD

2021-01-01 – 2021-12-31: 84000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 184.82 million
Calculation and evidence

-184736000 − 84000 USD

Exact free cash flow: -184820000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2022 2022-01-01 – 2022-12-31
−USD 241.32 million
Exact value

Exact value: -241317000 USD

2022-01-01 – 2022-12-31: -241317000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 219.99 million
Exact value

Exact value: -219987000 USD

2022-01-01 – 2022-12-31: -219987000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 1.71 million
Exact value

Exact value: 1705000 USD

2022-01-01 – 2022-12-31: 1705000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 221.69 million
Calculation and evidence

-219987000 − 1705000 USD

Exact free cash flow: -221692000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2023 2023-01-01 – 2023-12-31
−USD 198.64 million
Exact value

Exact value: -198643000 USD

2023-01-01 – 2023-12-31: -198643000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 173.16 million
Exact value

Exact value: -173164000 USD

2023-01-01 – 2023-12-31: -173164000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 615,000
Exact value

Exact value: 615000 USD

2023-01-01 – 2023-12-31: 615000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 173.78 million
Calculation and evidence

-173164000 − 615000 USD

Exact free cash flow: -173779000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2024 2024-01-01 – 2024-12-31
−USD 169.93 million
Exact value

Exact value: -169925000 USD

2024-01-01 – 2024-12-31: -169925000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 170.49 million
Exact value

Exact value: -170491000 USD

2024-01-01 – 2024-12-31: -170491000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 140,000
Exact value

Exact value: 140000 USD

2024-01-01 – 2024-12-31: 140000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 170.63 million
Calculation and evidence

-170491000 − 140000 USD

Exact free cash flow: -170631000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2025 2025-01-01 – 2025-12-31
−USD 52.49 million
Exact value

Exact value: -52489000 USD

2025-01-01 – 2025-12-31: -52489000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 58.14 million
Exact value

Exact value: -58135000 USD

2025-01-01 – 2025-12-31: -58135000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 155,000
Exact value

Exact value: 155000 USD

2025-01-01 – 2025-12-31: 155000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 58.29 million
Calculation and evidence

-58135000 − 155000 USD

Exact free cash flow: -58290000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

28 filings · 1,471 latest values · 1,471 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001832038, 1832038, ADGI, IVVD, edgar:1832038

Also known as Adagio Therapeutics, Inc., INVIVYD, INC., Invivyd, Inc.